-
Mashup Score: 3Webinars for Patients - 12 day(s) ago
NCCN Webinars for Patients feature experts as they discuss the best care for different cancer types.
Source: www.nccn.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 0Georgetown Lombardi Comprehensive Cancer Center - 24 day(s) ago
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet-
First-line Rybrevant plus Lazcluze improved survival versus the current standard of care in patients with mutated advanced or metastatic #NSCLC. @LombardiCancer #LungCancer Read more here: https://t.co/Tw1TfWrGfI
-
-
Mashup Score: 14
This multicenter cohort study develops and assesses the validity of a deep learning model for predicting immune checkpoint inhibitor response in patients with advanced non−small cell lung cancer.
Source: jamanetwork.comCategories: General Medicine News, Hem/OncsTweet-
Our Highlighted Article of the Week in Video Format 🚨 "Deep Learning Model for Predicting Immunotherapy Response in Advanced Non−Small Cell Lung Cancer" by @BiagioRicciutMD 🇺🇸 #NSCLC #LungCancer 🫁 Link Direct to Paper: https://t.co/jD4zUoVusC https://t.co/fqfOk2aM1B
-
-
Mashup Score: 3Webinars for Patients - 30 day(s) ago
NCCN Webinars for Patients feature experts as they discuss the best care for different cancer types.
Source: www.nccn.orgCategories: General Medicine News, Oncologists1Tweet-
Join us on January 17 for the FREE NCCN Patient Webinar focusing on Non-Small Cell Lung Cancer. This webinar is designed to help participants understand non-small cell lung cancer and its various treatment options. Register now: https://t.co/SbQbatffoK #NSCLC #LungCancer https://t.co/BouMtY5zEw
-
-
Mashup Score: 1Webinars for Patients - 2 month(s) ago
NCCN Webinars for Patients feature experts as they discuss the best care for different cancer types.
Source: www.nccn.orgCategories: General Medicine News, Oncologists1Tweet-
Join us on January 17 for the FREE NCCN Patient Webinar focusing on Non-Small Cell Lung Cancer. This webinar is designed to help participants understand non-small cell lung cancer and its various treatment options. Register now: https://t.co/SbQbatffoK #NSCLC #LungCancer https://t.co/BouMtY5zEw
-
-
Mashup Score: 37
For patients with unresectable stage III non–small-cell lung cancer (NSCLC), consolidation durvalumab is the standard of care after chemoradiation for
Source: www.jwatch.orgCategories: General Medicine News, General HCPsTweet-
Based on recent study findings, osimertinib after chemoradiation is a new standard of care for unresectable stage III non–small-cell lung cancer, writes @JPatelMD. https://t.co/zJIY3FlQAB #NSCLC #LungCancer https://t.co/2IOzrtQItd
-
-
Mashup Score: 1Targeted Therapies Continue to Infiltrate NSCLC Treatment | Docwire News - 11 month(s) ago
Although most of patients with NSCLC will receive immunotherapy, a growing percentage are eligible for targeted agents.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
Although most of patients with #NSCLC will receive immunotherapy, a growing percentage are eligible for targeted agents. #lungcancer Read More: https://t.co/egezMYrBYq https://t.co/MJu4op7ocE
-
-
Mashup Score: 1
Administering perioperative immunotherapy both before and after surgery significantly improves event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC), according to a study presented at the European Society for Medical Oncology Congress 2023. The CheckMate 77T trial was a randomized, double-blind study comprising more than 450 patients with NSCLC. The study subjects were randomized to treatment with either neoadjuvant nivolumab with chemotherapy followed by
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet-
Perioperative immunotherapy both before and after surgery significantly improves EFS in operable early-stage #NSCLC. #lungcancer https://t.co/OwLY3IkwCp https://t.co/hdqxo2KPdn
-
Join us on January 17 for the FREE NCCN Patient Webinar focusing on Non-Small Cell Lung Cancer. This webinar is designed to help participants understand non-small cell lung cancer and its various treatment options. Register now: https://t.co/SbQbatffoK #NSCLC #LungCancer https://t.co/BouMtY5zEw